YISHENG PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 24.13 million yuan, a year-on-year decrease of 32.72%
According to the Zhitong Finance APP, YISHENG PHARM disclosed its third-quarter report for 2025. The company achieved revenue of 476 million yuan in the first three quarters, a year-on-year decrease of 5.81%; the net profit attributable to the parent company was 24.13 million yuan, a year-on-year decrease of 32.72%; the net profit excluding non-recurring gains and losses was 12.56 million yuan, a year-on-year decrease of 37.81%; the basic earnings per share were 0.0729 yuan
According to the Zhitong Finance APP, YISHENG PHARM (002566.SZ) disclosed its third-quarter report for 2025. The company achieved a revenue of 476 million yuan in the first three quarters, a year-on-year decrease of 5.81%; the net profit attributable to the parent company was 24.13 million yuan, a year-on-year decrease of 32.72%; the net profit excluding non-recurring gains and losses was 12.56 million yuan, a year-on-year decrease of 37.81%; the basic earnings per share were 0.0729 yuan
